ARCHIVES

Amgen Cancels Rilotumumab Trials in Gastric Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Other News: ESAs Fail To Reduce Blood Transfusions, SEER Data Show

November 20, 2009

Also ASCO to release abstracts to members prior to annual meeting.

January 30, 2004

FDA Approves Evista for Breast Cancer Risk Reduction.

September 14, 2007

Reimbursement: NCI, VA Begin Project On Clinical Trials Access For Veterans

January 17, 1997

Nixon Resignation Won’t Hurt Cancer Program, Might Lead To More Money; Weinberger Stays

August 16, 1974

Group Sets Prostate Research Agenda; Strategy, Funding Demands to Follow

November 8, 1996